Teva Pharmaceuticals
TEVA
TEVA
428 hedge funds and large institutions have $5.14B invested in Teva Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 124 increasing their positions, 142 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
7% less capital invested
Capital invested by funds: $5.55B → $5.14B (-$411M)
13% less repeat investments, than reductions
Existing positions increased: 124 | Existing positions reduced: 142
15% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 40
Holders
428
Holding in Top 10
5
Calls
$296M
Puts
$315M
Top Buyers
| 1 | +$30.1M | |
| 2 | +$27.3M | |
| 3 | +$24.5M | |
| 4 |
Jane Street
New York
|
+$24.4M |
| 5 |
D.E. Shaw & Co
New York
|
+$24.3M |
Top Sellers
| 1 | -$404M | |
| 2 | -$35.4M | |
| 3 | -$21.9M | |
| 4 |
Citigroup
New York
|
-$17.5M |
| 5 |
JP Morgan Chase
New York
|
-$12M |